View this email in your browser
BIA Separations helps fighting COVID-19
Messenger RNA is poised to become a major contributor in the fields of gene therapy and vaccines, including Covid-19. BIA Separations offers the most advanced RNA purification toolbox in the field. Follow the links below for screening protocols and information about how to remove dsRNA, DNA, proteins, and short transcripts from your ssRNA samples with CIMmultus™ Oligo dT for hybridization-affinity chromatography, with CIMmultus C4 HLD for hydrophobic interaction chromatography, and with CIMmultus SDVB for reverse phase chromatography.
We will soon commence beta-testing of our advanced new anion exchanger that fractionates ssRNA by size in addition to removing contaminants before RNA elution, all at ambient temperature. Contact us about becoming a participant.
Setting a CORNERSTONE for Platform Purification of Exosomes
This powerful toolbox offers a unique approach to exosome purification, enabling the preparation of high quality research-grade exosomes. The process can be easily scaled up to meet the demands of development, validation, and manufacturing.
Get your pack
The growth of BIA Separations' expansion
Current COVID-19 situation has forced us to postpone our Monolith Summer Symposium to a later date (TBD), however, since we believe that this extra waiting time can be considered as a gift, we encourage you to make the most of it.
Do not be shy to share your knowledge and experience with monolith technology  - the deadline for abstract submission (for both posters and oral presentations) is August 31, 2020.
No matter when the event will be held; all of you who are interested are still kindly invited to register here.
Copyright © 2020 BIA Separations, All rights reserved.

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.

Email Marketing Powered by Mailchimp